The D3 dopamine receptor inhibits dopamine release in PC-12/hD3 cells by autoreceptor signaling via PP-2B, CK1, and Cdk-5

Journal of Neurochemistry

Volumn 110, Issue 4, 2009, Pages 1180-1190

  Chen, Pei Chun ^b   Lao, Chu Lan ^a   Chen, Jin Chung ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Autoinhibition; Cyclin dependent kinase 5; D3 dopamine receptor; Transmitter release

Indexed keywords

2 DIPROPYLAMINO 7 HYDROXYTETRALIN; 3 [(2,4,6 TRIMETHOXYPHENYL)METHYLIDENYL]INDOLIN 2 ONE; 3,4,4A,10B TETRAHYDRO 4 PROPYL 2H,5H [1]BENZOPYRANO[4,3 B][1,4]OXAZIN 9 OL; 3,6A,11,14 TETRAHYDRO 9 METHOXY 2 METHYL (12H) ISOQUINO[1,2 B]PYRROLO[3,2 F]BENZOXAZINE 1 CARBOXYLIC ACID; 4' ACETYL N [4 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]BUTYL]BIPHENYL 4 CARBOXAMIDE; CALCINEURIN; CASEIN KINASE I; CYCLIC AMP; CYCLIN DEPENDENT KINASE 5; CYCLIN DEPENDENT KINASE 5 INHIBITOR; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLOSPORIN A; DOPAMINE; DOPAMINE 3 RECEPTOR; DOPAMINE 3 RECEPTOR STIMULATING AGENT; DOPAMINE AUTORECEPTOR; FORSKOLIN; N [4 [2 (6 CYANO 1,2,3,4 TETRAHYDRO 2 ISOQUINOLINYL)ETHYL]CYCLOHEXYL] 4 QUINOLINECARBOXAMIDE; OLOMOUCINE; PERTUSSIS TOXIN; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PHOSPHOPROTEIN; PROTEIN KINASE B; QUINPIROLE; RACLOPRIDE; ROSCOVITINE; UNCLASSIFIED DRUG; WORTMANNIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DOPAMINE RELEASE; DOPAMINERGIC NERVE CELL; DOSE RESPONSE; DRUG RECEPTOR BINDING; HORMONE RECEPTOR INTERACTION; HUMAN; HUMAN CELL; INHIBITION KINETICS; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; AUTORECEPTORS; CALCINEURIN; CASEIN KINASE I; CLONE CELLS; CYCLIC AMP; CYCLIN-DEPENDENT KINASE 5; DOPAMINE; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; ENZYME INHIBITORS; FEEDBACK, BIOCHEMICAL; HUMANS; NEURONS; PC12 CELLS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RECEPTORS, DOPAMINE D3; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 67651153041     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2009.06209.x     Document Type: Article

References (29)

1. 2+- stimulated catecholamine release from alpha-toxin-permeabilized PC12 cells: biochemical evidence for exocytosis and its modulation by protein kinase C and G proteins. Biochemistry 26, 7842 7848.
2. Beaulieu J. M., Sotnikova T. D., Yao W. D., Kockeritz L., Woodgett J. R., Gainetdinov R. R. Caron M. G. (2004) Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade. Proc. Natl Acad. Sci. USA 101, 5099 5104.
3. Bibb J. A., Chen J., Taylor J. R. et al. (2001) Effects of chronic exposure to cocaine are regulated by the neuronal protein Cdk5. Nature 410, 376 380.
4. Chen P. C. Chen J. C. (2005) Enhanced Cdk5 activity and p35 translocation in the ventral striatum of acute and chronic methamphetamine-treated rats. Neuropsychopharmacology 30, 538 549.
5. Chergui K., Svenningsson P. Greengard P. (2004) Cyclin-dependent kinase 5 regulates dopaminergic and glutamatergic transmission in the striatum. Proc. Natl Acad. Sci. USA 101, 2191 2196.
6. Chiang Y. C., Chen P. C. Chen J. C. (2003) D(3) dopamine receptors are down-regulated in amphetamine sensitized rats and their putative antagonists modulate the locomotor sensitization to amphetamine. Brain Res. 972, 159 167.
7. Courtney N. D., Howlett A. C. Westfall T. C. (1991) Regulation of nicotine-evoked dopamine release from PC12 cells. Life Sci. 48, 1671 1678.
8. Cussac D., Newman-Tancredi A., Pasteau V. Millan M. J. (1999) Human dopamine D(3) receptors mediate mitogen-activated protein kinase activation via a phosphatidylinositol 3-kinase and an atypical protein kinase C-dependent mechanism. Mol. Pharmacol. 56, 1025 1030.
9. Diaz J., Pilon C., Le Foll B., Gros C., Triller A., Schwartz J. C. Sokoloff P. (2000) Dopamine D3 receptors expressed by all mesencephalic dopamine neurons. J. Neurosci. 20, 8677 8684.
10. Fletcher A. I., Shuang R., Giovannucci D. R., Zhang L., Bittner M. A. Stuenkel E. L. (1999) Regulation of exocytosis by cyclin-dependent kinase 5 via phosphorylation of Munc18. J. Biol. Chem. 274, 4027 4035.
11. Greengard P. (2001) The neurobiology of slow synaptic transmission. Science 294, 1024 1030.
12. 2+ currents and excitability via a novel PLC[beta]1-IP3-calcineurin-signaling cascade. J. Neurosci. 20, 8987 8995.
13. Joseph J. D., Wang Y. M., Miles P. R., Budygin E. A., Picetti R., Gainetdinov R. R., Caron M. G. Wightman R. M. (2002) Dopamine autoreceptor regulation of release and uptake in mouse brain slices in the absence of D(3) receptors. Neuroscience 112, 39 49.
14. Koeltzow T. E., Xu M., Cooper D. C., Hu X. T., Tonegawa S., Wolf M. E. White F. J. (1998) Alterations in dopamine release but not dopamine autoreceptor function in dopamine D3 receptor mutant mice. J. Neurosci. 18, 2231 2238.
15. Kuzhikandathil E. V. Oxford G. S. (1999) Activation of human D3 dopamine receptor inhibits P/Q-type calcium channels and secretory activity in AtT-20 cells. J. Neurosci. 19, 1698 1707.
16. Liu F., Ma X. H., Ule J., Bibb J. A., Nishi A., DeMaggio A. J., Yan Z., Nairn A. C. Greengard P. (2001) Regulation of cyclin-dependent kinase 5 and casein kinase 1 by metabotropic glutamate receptors. Proc. Natl Acad. Sci. USA 98, 11062 11068.
17. Mashhoon N., DeMaggio A. J., Tereshko V., Bergmeier S. C., Egli M., Hoekstra M. F. Kuret J. (2000) Crystal structure of a conformation-selective casein kinase-1 inhibitor. J. Biol. Chem. 275, 20052 20060.
18. Murthy K. S., Zhou H., Huang J. Pentyala S. N. (2004) Activation of PLC-delta1 by Gi/o-coupled receptor agonists. Am. J. Physiol. Cell Physiol. 287, C1679 C1687.
19. Pedrosa R., Gomes P., Hopfer U., Jose P. A. Soares-da-Silva P. (2004) Gialpha3 protein-coupled dopamine D3 receptor-mediated inhibition of renal NHE3 activity in SHR proximal tubular cells is a PLC-PKC-mediated event. Am. J. Physiol. Renal Physiol. 287, F1059 F1066.
20. Richtand N. M., Woods S. C., Berger S. P. Strakowski S. M. (2001) D3 dopamine receptor, behavioral sensitization, and psychosis. Neurosci. Biobehav. Rev. 25, 427 443.
21. Robinson S. W. Caron M. G. (1997) Selective inhibition of adenylyl cyclase type V by the dopamine D3 receptor. Mol. Pharmacol. 52, 508 514.
22. Schmidt M., Lohmann B., Hammer K., Haupenthal S., Nehls M. V. Jakobs K. H. (1998) Gi- and protein kinase C-mediated heterologous potentiation of phospholipase C signaling by G protein-coupled receptors. Mol. Pharmacol. 53, 1139 1148.
23. Sharma P., Sharma M., Amin N. D., Albers R. W. Pant H. C. (1999) Regulation of cyclin-dependent kinase 5 catalytic activity by phosphorylation. Proc. Natl Acad. Sci. USA 96, 11156 11160.
24. Sokoloff P., Diaz J., Le Foll B., Guillin O., Leriche L., Bezard E. Gross C. (2006) The dopamine D3 receptor: a therapeutic target for the treatment of neuropsychiatric disorders. CNS Neurol. Disord. Drug Targets 5, 25 43.
25. Svenningsson P., Nishi A., Fisone G., Girault J.-A., Nairn A. C. Greengard P. (2004) DARPP-32: an integrator of neurotransmission. Annu. Rev. Pharmacol. Toxicol. 44, 269 296.
26. Tan T. C., Valova V. A., Malladi C. S. et al. (2003) Cdk5 is essential for synaptic vesicle endocytosis. Nat. Cell Biol. 5, 701 710.
27. Tang L., Todd R. D. O'Malley K. L. (1994) Dopamine D2 and D3 receptors inhibit dopamine release. J. Pharmacol. Exp. Ther. 270, 475 479.
28. Tomizawa K., Ohta J., Matsushita M., Moriwaki A., Li S. T., Takei K. Matsui H. (2002) Cdk5/p35 regulates neurotransmitter release through phosphorylation and downregulation of P/Q-type voltage-dependent calcium channel activity. J. Neurosci. 22, 2590 2597.
29. Tomizawa K., Sunada S., Lu Y. F. et al. (2003) Cophosphorylation of amphiphysin I and dynamin I by Cdk5 regulates clathrin-mediated endocytosis of synaptic vesicles. J. Cell Biol. 163, 813 824.